A recent study from Alzheimer’s disease researchers at the University of Wisconsin–Madison used neuroimaging technology called 4D Flow MRI to study the relationship between blood vessel disease and Alzheimer’s disease. Published in December 2021, the study found that people with Alzheimer’s disease symptoms had stiffer blood vessels in their brains, which could lead to inflammation and a buildup of Alzheimer’s biomarkers like amyloid and tau proteins. Lead researcher Leonardo Rivera-Rivera joins the podcast to discuss his findings, the developments made with new 4D Flow MRI scans, and how these developments could impact future Alzheimer’s disease research and clinical practices.
Guest: Leonardo Rivera-Rivera, PhD, neuroimaging scientist, Wisconsin Alzheimer’s Disease Research Center
Episode Topics8:55 How does the 4D Flow MRI technology used in your study compare to MRIs used in clinics?
13:18 What did you look at in your study? What were your findings?
17:54 Did you see more pronounced findings in particular individuals with APOE4 or other chronic conditions like diabetes?
20:37 Why is this an important finding for Alzheimer’s disease research? Do you think 4D flow MRIs could be incorporated into clinical settings?
Show NotesRead Leonardo Rivera-Rivera’s publication “Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers,” published in the journal Alzheimer’s and Dementia: Diagnosis, Assessment & Disease Monitoring.
Learn more about Leonardo Rivera-Rivera’s research at the Wisconsin Alzheimer’s Disease Research Center website.
Alcohol and the Brain: One Drink a Day Associated with Brain Shrinkage
Women’s Health Month: Women and Alzheimer’s Disease
Disaggregating Racial Data: How Studying Ethnic Subgroups Can Improve Research
Incorporating Cultural Knowledge: Improving Alzheimer’s Disease Research for Veterans and Native Americans
Update on Blood Tests for Alzheimer’s Disease
Harnessing the Power of Autophagy to Treat Alzheimer’s Disease
Breaking Down Medicare’s Proposed Decision on Aducanumab and Monoclonal Antibody Treatments
Nasal Vaccine for Alzheimer’s Disease Enters Clinical Trial
‘American Dementia’: Author Interview with Dr. Daniel George and Dr. Peter Whitehouse
New Research Shifts Thinking on Metabolism and Aging
Aging Behind the Wheel: How Driving Behavior Can Identify Preclinical Alzheimer’s Disease
Global Challenges in Dementia Diagnosis: A Deep Dive into ADI’s World Alzheimer’s Report 2021
Accessibility and Community: Bringing Alzheimer’s and Dementia Resources to the Latinx Community
You Are What You Eat: Study of Diet and Brain Health Shows Cognitive Benefits from Cheese, Wine and Lamb
AARP Study Shows Stigma Surrounding Dementia among Healthcare Professionals and General Public
Caregivers, Care Partners and People with Dementia: Brainstorming New Interventions for Dementia Care
Tackling Stigma and Alzheimer’s Disease within the AAPI Community
Creative Care: The Power of Imagination in Dementia Caregiving
Better Now than Never: Quit Smoking to Reduce Your Risk for Alzheimer’s Disease
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks